Exploring Interactions Between Growth Hormone and the Microbiome

Rambam Health Care Campus200 enrolled

Overview

The goal of this study is to characterize the microbiome and metabolomics of children with Growth Hormone (GH) deficiency, prior GH treatment initiation and compare it to healthy children

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Growth Hormone Deficiency

Interventions

Non InterventionalOTHER

Non Interventional

Eligibility

Sex: ALLMin age: 3 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children with GH deficiency Exclusion Criteria: * Turner syndrome * End state renal disease (ESRD) * Prader-Willi syndrome * Systemic illness * Antibiotics/Antifungal in the last 3m

Locations (1)

Pediatric endocrinology unit rambam medical center

Haifa, Israel

RECRUITING

Outcomes

Primary Outcomes

Changes in the microbiome population following Growth hormone treatment

Time frame: 1 year

Central Contacts

Smadar Shilo, Dr

CONTACT

89344307 smadar.shilo@weizmann.ac.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.